Tags

Type your tag names separated by a space and hit enter

Oral miltefosine to treat new world cutaneous leishmaniasis.
Lancet Infect Dis. 2007 Jan; 7(1):7.LI

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comment
Comparative Study
Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17182338

Citation

Soto, Jaime, and Julia T. Toledo. "Oral Miltefosine to Treat New World Cutaneous Leishmaniasis." The Lancet. Infectious Diseases, vol. 7, no. 1, 2007, p. 7.
Soto J, Toledo JT. Oral miltefosine to treat new world cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(1):7.
Soto, J., & Toledo, J. T. (2007). Oral miltefosine to treat new world cutaneous leishmaniasis. The Lancet. Infectious Diseases, 7(1), 7.
Soto J, Toledo JT. Oral Miltefosine to Treat New World Cutaneous Leishmaniasis. Lancet Infect Dis. 2007;7(1):7. PubMed PMID: 17182338.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oral miltefosine to treat new world cutaneous leishmaniasis. AU - Soto,Jaime, AU - Toledo,Julia T, PY - 2006/12/22/pubmed PY - 2007/1/20/medline PY - 2006/12/22/entrez SP - 7 EP - 7 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 7 IS - 1 SN - 1473-3099 UR - https://www.unboundmedicine.com/medline/citation/17182338/Oral_miltefosine_to_treat_new_world_cutaneous_leishmaniasis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(06)70665-X DB - PRIME DP - Unbound Medicine ER -